Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00498-x)

Bernard G. Combe; Yoshiya Tanaka; Maya H. Buch; Peter Nash; Gerd R. Burmester; Alan J. Kivitz; Beatrix Bartok; Alena Pechonkina; Katrina Xia; Kahaku Emoto; Shungo Kano; Thijs K. Hendrikx; Robert B. M. Landewé; Daniel Aletaha

doi:https://doi.org/10.1007/s40744-022-00530-0

Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00498-x)

Bernard G. Combe, Yoshiya Tanaka, Maya H. Buch, Peter Nash, Gerd R. Burmester, Alan J. Kivitz, Beatrix Bartok, Alena Pechonkina, Katrina Xia, Kahaku Emoto, Shungo Kano, Thijs K. Hendrikx, Robert B. M. Landewé, Daniel Aletaha

Research output: Contribution to journal › Comment/Letter to the editor › Academic

1 Citation (Scopus)

Abstract

In this article the legend for Fig. 5 was inadvertently with error, the legend for Fig. 5 should have appeared as shown below.

Original language	English
Pages (from-to)	71-72
Number of pages	2
Journal	Rheumatology and therapy
Volume	10
Issue number	1
Early online date	2023
DOIs	https://doi.org/10.1007/s40744-022-00530-0
Publication status	Published - Feb 2023

Access to Document

https://doi.org/10.1007/s40744-022-00530-0

Cite this

Combe, B. G., Tanaka, Y., Buch, M. H., Nash, P., Burmester, G. R., Kivitz, A. J., Bartok, B., Pechonkina, A., Xia, K., Emoto, K., Kano, S., Hendrikx, T. K., Landewé, R. B. M., & Aletaha, D. (2023). Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00498-x). Rheumatology and therapy, 10(1), 71-72. https://doi.org/10.1007/s40744-022-00530-0

@article{fc555838f9214701b1009c0c19098ca7,

title = "Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00498-x)",

abstract = "In this article the legend for Fig. 5 was inadvertently with error, the legend for Fig. 5 should have appeared as shown below.",

author = "Combe, {Bernard G.} and Yoshiya Tanaka and Buch, {Maya H.} and Peter Nash and Burmester, {Gerd R.} and Kivitz, {Alan J.} and Beatrix Bartok and Alena Pechonkina and Katrina Xia and Kahaku Emoto and Shungo Kano and Hendrikx, {Thijs K.} and Landew{\'e}, {Robert B. M.} and Daniel Aletaha",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = feb,

doi = "https://doi.org/10.1007/s40744-022-00530-0",

language = "English",

volume = "10",

pages = "71--72",

journal = "Rheumatology and therapy",

issn = "2198-6576",

publisher = "Adis International Ltd",

number = "1",

}

Combe, BG, Tanaka, Y, Buch, MH, Nash, P, Burmester, GR, Kivitz, AJ, Bartok, B, Pechonkina, A, Xia, K, Emoto, K, Kano, S, Hendrikx, TK, Landewé, RBM & Aletaha, D 2023, 'Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00498-x)', Rheumatology and therapy, vol. 10, no. 1, pp. 71-72. https://doi.org/10.1007/s40744-022-00530-0

Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00498-x). / Combe, Bernard G.; Tanaka, Yoshiya; Buch, Maya H. et al.
In: Rheumatology and therapy, Vol. 10, No. 1, 02.2023, p. 71-72.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Correction

T2 - Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00498-x)

AU - Combe, Bernard G.

AU - Tanaka, Yoshiya

AU - Buch, Maya H.

AU - Nash, Peter

AU - Burmester, Gerd R.

AU - Kivitz, Alan J.

AU - Bartok, Beatrix

AU - Pechonkina, Alena

AU - Xia, Katrina

AU - Emoto, Kahaku

AU - Kano, Shungo

AU - Hendrikx, Thijs K.

AU - Landewé, Robert B. M.

AU - Aletaha, Daniel

PY - 2023/2

Y1 - 2023/2

N2 - In this article the legend for Fig. 5 was inadvertently with error, the legend for Fig. 5 should have appeared as shown below.

AB - In this article the legend for Fig. 5 was inadvertently with error, the legend for Fig. 5 should have appeared as shown below.

UR - http://www.scopus.com/inward/record.url?scp=85145584252&partnerID=8YFLogxK

U2 - https://doi.org/10.1007/s40744-022-00530-0

DO - https://doi.org/10.1007/s40744-022-00530-0

M3 - Comment/Letter to the editor

C2 - 36598735

SN - 2198-6576

VL - 10

SP - 71

EP - 72

JO - Rheumatology and therapy

JF - Rheumatology and therapy

IS - 1

ER -

Combe BG, Tanaka Y, Buch MH, Nash P, Burmester GR, Kivitz AJ et al. Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00498-x). Rheumatology and therapy. 2023 Feb;10(1):71-72. Epub 2023. doi: https://doi.org/10.1007/s40744-022-00530-0

Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00498-x)

Abstract

Access to Document

Other files and links

Cite this